These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8839816

  • 21. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.
    Atalar E, Eskin F, Tugtekin HB, Karabulut A, Kanyilmaz S, Kirbiyik H, Ozyildiz AG.
    Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020
    [Abstract] [Full Text] [Related]

  • 22. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
    Holzgreve H, Nakov R, Beck K, Janka HU.
    Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
    [Abstract] [Full Text] [Related]

  • 23. Once-daily fixed dose combinations of verapamil and trandolapril in black patients with mild to moderate hypertension: a new choice for first line treatment.
    Skoularigis J, Strugo V, Radevski I, Hlatswayo Z, Sareli P.
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):51-5. PubMed ID: 9147707
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators.
    N Engl J Med; 2004 Nov 04; 351(19):1941-51. PubMed ID: 15516697
    [Abstract] [Full Text] [Related]

  • 26. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G, BENEDICT Study Group.
    J Am Soc Nephrol; 2006 Dec 04; 17(12):3472-81. PubMed ID: 17082240
    [Abstract] [Full Text] [Related]

  • 27. Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial.
    PROCOPA Study Group.
    J Hypertens; 2002 Apr 04; 20(4):729-37. PubMed ID: 11910310
    [Abstract] [Full Text] [Related]

  • 28. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
    Ruilope LM, de la Sierra A, Moreno E, Fernández R, Garrido J, de la Figuera M, de la Cámara AG, Coca A, Luque-Otero M.
    J Hypertens; 1999 Dec 04; 17(12 Pt 2):1917-23. PubMed ID: 10703890
    [Abstract] [Full Text] [Related]

  • 29. [Duration of action of trandolapril in mild to moderate hypertensive patients evaluated by ambulatory measurement of blood pressure].
    Kownator S, Dutrey-Dupagne C, Vaur L, Chevrier J, Diesel J, D'Hotel R, Schaaf R, Courvoisier A, Breton C.
    Therapie; 1994 Dec 04; 49(2):89-93. PubMed ID: 7817355
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M.
    J Hypertens Suppl; 1997 Mar 04; 15(2):S27-33. PubMed ID: 9218195
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
    Steiner G, Pauly NC.
    J Cardiovasc Pharmacol; 1994 Mar 04; 23 Suppl 4():S81-5. PubMed ID: 7527108
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ.
    Blood Press Suppl; 2007 Mar 04; 1():6-9. PubMed ID: 17566313
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T, Janicki K, Klima M, Pieniazek W, Bednarz S.
    Przegl Lek; 1996 Mar 04; 53(2):73-7. PubMed ID: 8754325
    [Abstract] [Full Text] [Related]

  • 39. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R, García Robles R, Rodríguez Pérez JC, Gómez Pajuelo C, Moreno Carretero E, Grupo de estudio MICROTRAN.
    Nefrologia; 2001 Mar 04; 21(5):456-63. PubMed ID: 11795014
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.